Emphysematous gastritis due to hypervirulent Klebsiella pneumoniae - 27/10/22
Doi : 10.1016/S1473-3099(22)00545-X
Naomi Saeki, MD a, c, Kentaro Takei, MD c, d, Ken Katsuta, MD b, Akihiko Nakasato, MD a, b, Hiroaki Baba, MD PhD c, d, Kengo Oshima, MD PhD c, d, Koichi Tokuda, MD PhD c, d, Shigeki Kushimoto, MD PhD b, e, Hajime Kanamori, MD PhD c, d, ⁎ 
a Graduate Medical Education Center, Tohoku University Graduate School of Medicine, Tohoku University, Sendai, Japan
b Department of Emergency and Critical Care, Tohoku University Graduate School of Medicine, Tohoku University, Sendai, Japan
c Tohoku University Hospital, Department of Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Tohoku University, Sendai, Japan
d Department of Intelligent Network for Infection Control, Tohoku University Graduate School of Medicine, Tohoku University, Sendai, Japan
e Division of Emergency and Critical Care Medicine, Tohoku University Graduate School of Medicine, Tohoku University, Sendai, Japan
* Correspondence to: Dr Hajime Kanamori, Department of Infectious Diseases, Internal Medicine, Tohoku University Graduate School of Medicine, Sendai 980–8574, Japan Department of Infectious Diseases Internal Medicine Tohoku University Graduate School of Medicine Sendai 980–8574 Japan
Le texte complet de cet article est disponible en PDF.
© 2022
Elsevier Ltd. Tous droits réservés.
Vol 22 - N° 11
P. 1648 - novembre 2022 Retour au numéro
Article précédent
- Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control
- Javier Gandasegui, Chukwuemeka Onwuchekwa, Alejandro J Krolewiecki, Stephen R Doyle, Rachel L Pullan, Wendemagegn Enbiale, Stella Kepha, Hollie Ann Hatherell, Lisette van Lieshout, María Cambra-Pellejà, Valdemiro Escola, José Muñoz
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?